Global Representatives

These companies represent EPAX. Please contact us if you are interested in other countries than listed below, or if you have other enquires.


Australia and New Zealand

Pathway International Pty Limited
Phone: 
+61 2 9984 2700
Fax:
+61 2 9984 2755
E-mail: psm://sales@pathway.net.au
Web:
www.pathway.net.au

France, Spain and Portugal

Polaris
Phone:
+33 (0) 298 548 420
Fax: +33 (0) 298 548 451
E-mail: psm://contact@polaris.fr
Web: http://www.polaris.fr/

Germany, Austria and Switzerland

Goerlich Pharma International GmbH
Phone: 
+49 (0) 8071 9083 0
Fax: +49 (0) 8071 9083 29
E-mail:
psm://info@goerlich-pharma.com
Web:
www.goerlich-pharma.com

Italy

Reinor s.a.s
Phone: 
+39 02 65 51 122
Fax:
+39 02 65 70 044
E-mail: psm://reinor@reinorsas.191.it

Japan

Morimura Bros Inc
Phone: 
+81 3 3502 6431
Fax: +81 3 3503 2002
E-mail: psm://sales-hq@morimura.co.jp
Web: http://www.morimura.co.jp/e_index/index.html
   

Nordic region

Silvaco A/S
Phone: 
+45 482 40 222
Fax:
+45 482 40 622
E-mail:
psm://info@silvaco.dk
Web: http://www.silvaco.dk/

North-America

Pharmline Inc
Phone: 
+1 845 651 4443
Fax: +1 845 651 6900
E-mail: psm://info@pharmlineinc.com
Web: www.pharmlineinc.com

South Korea

Sungwoo Interchem Corp.
Phone: 
+82 2 838 3871
Fax: +82 2 838 3874
E-mail:
psm://swic21@kornet.net
Web: www.sung-woo.com

Thailand

Helm Mahaboon Ltd
Phone: 
+ 66 2 273 8140
Fax:
+ 66 2 273 8137
E-mail:
psm://food@helmmahaboon.com
Web:
www.helmmahaboon.com
 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map        Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com